Nonprimate Lentiviral Vectors

  • M. A. Curran
  • G. P. Nolan
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 261)


Advances in the nascent field of gene therapy have created a demand for gene transfer vehicles that are capable of safely and stably delivering genes to both dividing and nondividing cells. Retroviral vectors, by virtue of their ability to permanently integrate genes of interest into the target cell genome, have played a prominent role in much of the gene transfer research to date. However, their inability to transduce quiescent cells has rendered them largely ineffective for clinical applications. In contrast, adenoviral vectors are capable of infecting nondividing cells, but attempts to move these vectors into the clinic have been limited at times by their lack of stable expression and high immunogenicity. Lentiviral vectors offer a unique combination of the advantages of these two systems without many of the pitfalls. Lentiviruses can stably transduce both dividing and nondividing cells, and, unlike adenoviral vectors, are not immunogenic in vivo. The most established and tested lentiviral vectors are those based on the human immunodeficiency virus (HIV-1). As a full-length virus, HIV is naturally optimized for production in and transduction of human cells and, as such, has proved an ideal candidate for development into a human gene transfer vector. Concern over the consequences of using vectors based on a pathogenic virus with such an optimized tropism for human cells has, however, limited the clinical applications of HIV vectors. For these reasons, vector development has begun to shift to other members of the lentivirus family that do not infect primates as part of their normal host range. In addition to the potential biosafety benefits, it is possible that some nonprimate lentiviral vectors will show an increased ability to infect some useful cell types relative to HIV-based vectors. As many of these viruses have not been well characterized biologically, an interesting cross-talk has developed where advances in lentiviral biology impact vector development and vice versa. The recent discovery of the central DNA flap in lentiviral genomes and its role in nuclear import of preintegration complexes, for example, may prove critical in bringing the efficiency of nonprimate lentiviral vectors up to the level of HIV vectors. As it appears that these nonprimate vectors might reach parity with their primate counterparts in terms of efficiency and tropism, it must now be considered whether they are truly safer for use in the clinic. This review will focus on those aspects of nonprimate lentiviral biology which make such vectors potentially useful in clinical settings.


Equine Infectious Anemia Virus Ciency Virus Nondividing Cell Packaging Cell Line Gene Transfer Vector 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abergel C, Robertson DL, Claverie JM (1999) “Hidden” dUTPase sequence in human immunodeficiency virus type 1 gpl 20. J Virol 73:751–753PubMedGoogle Scholar
  2. Alisky JM, Hughes SM, Sauter SL, Jolly D, Dubensky TWJ, Staber PD, Chiorini JA, Davidson BL (2000) Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11:2669–2673PubMedCrossRefGoogle Scholar
  3. Bray M, Prasad S, Dubay JW, Hunter E, Jeang KT, Rekosh D, Hammarskjöld ML (1994) A small element from the Mason-Pflzer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci USA 91:1256–1260PubMedCrossRefGoogle Scholar
  4. Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M (1993) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells [see comments]. Nature 365:666–669PubMedCrossRefGoogle Scholar
  5. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 89:6580–6584PubMedCrossRefGoogle Scholar
  6. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells [see comments]. Proc Natl Acad Sci USA 90:8033–8037PubMedCrossRefGoogle Scholar
  7. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini L, Kohn DB, Crooks GM (1999) Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 96:2988–2993PubMedCrossRefGoogle Scholar
  8. Chadwick BJ, Desport M, Brownlie J, Wilcox GE, Dharma DM (1998) Detection of Jembrana disease virus in spleen, lymph nodes, bone marrow and other tissues by in situ hybridization of paraffinembedded sections. J Gen Virol 79:101–106PubMedGoogle Scholar
  9. Chameau P, Mirambeau G, Roux P, Paulous S, Buc H, Clavel F (1994) HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol 241:651–662CrossRefGoogle Scholar
  10. Chen H, He J, Fong S, Wilcox G, Wood C (2000) Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication. J Virol 74:2703–2713PubMedCrossRefGoogle Scholar
  11. Chen W, Wu X, Levasseur DN, Liu H, Lai L, Kappes JC, Townes, TM (2000) Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 18:352–359PubMedCrossRefGoogle Scholar
  12. Chinnasamy N, Chinnasamy D, Toso J, Lapointe R, Candotti F, Morgan R, Hwu P (2000) Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors. Hum Gene Ther 11:1901–1909PubMedCrossRefGoogle Scholar
  13. Curran MA, Kaiser SM, Achacoso PL, Nolan GP (2000) Efficient Transduction of Non-Dividing Cells by Optimized Feline Immunodeficiency Virus Vectors. Mol Ther 1:31–38PubMedCrossRefGoogle Scholar
  14. Curran MA, Ochoa MS, Inverardi L, Ricordi C, Nolan GP, Fenjves ES (2001) Efficient Transduction of Pancreatic Islets by a Feline Immunodeficiency Virus Vector. Diabetes (in press)Google Scholar
  15. Dean GA, Reubel GH, Moore PF, Pedersen NC (1996) Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node. J Virol 70:5165–5169PubMedGoogle Scholar
  16. DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL, Jolly DJ, Dubensky TW Jr(2000) VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2:218–222PubMedCrossRefGoogle Scholar
  17. Dharma DM, Budiantono A, Campbell RS, Ladds PW (1991) Studies on experimental Jembrana disease in Bali cattle. III. Pathology. J Comp Pathol 105:397–414PubMedCrossRefGoogle Scholar
  18. Donello JE, Loeb JE, Hope TJ (1998) Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72:5085–5092PubMedGoogle Scholar
  19. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7:379–387PubMedGoogle Scholar
  20. Elder JH, Lerner DL, Hasselkus-Light CS, Fontenot DJ, Hunter E, Luciw PA, Montelaro RC, Phillips TR (1992) Distinct subsets of retroviruses encode dUTPase. J Virol 66:1791–1794PubMedGoogle Scholar
  21. Ernst RK, Bray M, Rekosh D, Hammarskjöld ML (1997) A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol Cell Biol 17:135–144PubMedGoogle Scholar
  22. Evans JT, Kelly PF, O’Neill E, Garcia JV (1999) Human cord blood CD34 + CD38-cell transduction via lentivirus-based gene transfer vectors. Hum Gene Ther 10:1479–1489PubMedCrossRefGoogle Scholar
  23. Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L (2000) Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25:217–222PubMedCrossRefGoogle Scholar
  24. Fong SE, Greenwood JD, Williamson JC, Derse D, Pallansch LA, Copeland T, Rasmussen L, Mentzer A, Nagashima K, Tobin G, Gonda MA (1997) Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products. Virology 233:339–357PubMedCrossRefGoogle Scholar
  25. Gallay P, Hope T, Chin D, Trono D (1997) HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 94:9825–9830PubMedCrossRefGoogle Scholar
  26. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D (1996) Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. J Virol 70:1027–1032PubMedGoogle Scholar
  27. Gallay P, Swingler S, Aiken C, Trono D (1995) HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379–388PubMedCrossRefGoogle Scholar
  28. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 9:2717–2726PubMedCrossRefGoogle Scholar
  29. Giannoukakis N, Mi Z, Gambotto A, Eramo A, Ricordi C, Trucco M, Robbins P (1999) Infection of intact human islets by a lentiviral vector. Gen Ther 6:1545–1551CrossRefGoogle Scholar
  30. Gonda MA, Luther DG, Fong SE, Tobin GJ (1994) Bovine immunodeficiency virus: molecular biology and virus-host interactions. Virus Res 32:155–181PubMedCrossRefGoogle Scholar
  31. Graham FL, Smiley J, Russell WC, Nairn R (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74PubMedCrossRefGoogle Scholar
  32. Harris JM, Mclntosh EM, Muscat GE (2000) Expression and cytoplasmic localisation of deoxyuridine triphosphate pyrophosphatase encoded by a human endogenous retrovirus. Archives of Virology 145:353–363PubMedCrossRefGoogle Scholar
  33. Hartmann K (1998) Feline immunodeficiency virus infection: an overview. Vet J 155:123–137PubMedCrossRefGoogle Scholar
  34. Heaton PR, Johnstone P, Brownlie J (1998) Investigation of the cellular tropism of bovine immunodeficiency-like virus. Research in Veterinary Science 65:33–40PubMedCrossRefGoogle Scholar
  35. Hein A, Martin JP, Koehren F, Bingen A, Dörries R (2000) In vivo infection of ramified microglia from adult cat central nervous system by feline immunodeficiency virus. Virology 268:420–429PubMedCrossRefGoogle Scholar
  36. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA 91:7311–7315PubMedCrossRefGoogle Scholar
  37. Huang ZM, Yen TS (1994) Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J Virol 68:3193–3199PubMedGoogle Scholar
  38. Ikeda Y, Tomonaga K, Kawaguchi Y, Kohmoto M, Inoshima Y, Tohya Y, Miyazawa T, Kai C, Mikami T (1996) Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells. J Gen Virol 77:1623–1630PubMedCrossRefGoogle Scholar
  39. Joag SV, Stephens EB, Opendra N (1996) Lentiviruses. In: Fields BN et al. (eds) Fields Virology. Lippincott, Raven Press, New YorkGoogle Scholar
  40. Johnston J, Power C (1999) Productive infection of human peripheral blood mononuclear cells by feline immunodeficiency virus: implications for vector development. J Virol 73:2491–2498PubMedGoogle Scholar
  41. Johnston JC, Gasmi M, Lim LE, Elder JH, Yee JK, Jolly DJ, Campbell KP, Davidson BL, Sauter SL (1999) Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J Virol 73:4991–5000PubMedGoogle Scholar
  42. Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG, Brownlee M (1998) Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41:736–739PubMedCrossRefGoogle Scholar
  43. Kafri T, Blömer U, Peterson DA, Gage FH, Verma IM (1997) Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet 17:314–317PubMedCrossRefGoogle Scholar
  44. Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM (1999) A packaging cell line for lentivirus vectors. J Virol 73:576–584PubMedGoogle Scholar
  45. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD (1994) Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91:7071–7075PubMedCrossRefGoogle Scholar
  46. Kinoshita S, Chen BK, Kaneshima H, Nolan GP (1998) Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 95:595–604PubMedCrossRefGoogle Scholar
  47. Kordower J, Emborg M, Bloch J, Ma S, Chu Y, Leventhal L, McBride J, Chen E, Palfi S, Roitberg B, Brown W, Holden J, Pyzalski R, Taylor M, Carvey P, Ling Z, Trono D, Hantraye P, Deglon N, PA (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson’s disease. Science 290:767–773PubMedCrossRefGoogle Scholar
  48. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A, Levine F (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48:745–753PubMedCrossRefGoogle Scholar
  49. Lerner DL, Wagaman PC, Phillips TR, Prospero-Garcia O, Henriksen SJ, Fox HS, Bloom FE, Elder JH (1995) Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad Sci USA 92:7480–7484PubMedCrossRefGoogle Scholar
  50. Lewis PF, Emerman M (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68:510–516PubMedGoogle Scholar
  51. Li KJ, Garoff H (1996) Production of infectious recombinant Moloney murine leukemia virus particles in BHK cells using Semliki Forest virus-derived RNA expression vectors. Proc Natl Acad Sci USA 93:11658–11663PubMedCrossRefGoogle Scholar
  52. Lockridge KM, Chien M, Dean GA, Stefano Cole K, Montelaro RC, Luciw PA, Sparger EE (2000) Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 273:67–79PubMedCrossRefGoogle Scholar
  53. Mansky LM, Preveral S, Selig L, Benarous R, Benichou S (2000) The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J Virol 74:7039–7047PubMedCrossRefGoogle Scholar
  54. Mautino MR, Keiser N, Morgan RA (2000) Improved titers of HIV-based lentiviral vectors using the SRV-1 constitutive transport element. Gen Ther 7:1421–1424CrossRefGoogle Scholar
  55. McIntosh EM, Haynes RH (1996) HIV and human endogenous retroviruses: an hypothesis with therapeutic implications. Acta Biochim Pol 43:583–592PubMedGoogle Scholar
  56. Metharom P, Takyar S, Xia HH, Ellem KA, Macmillan J, Shepherd RW, Wilcox GE, Wei MQ (2000) Novel bovine lentiviral vectors based on Jembrana disease virus. J Gene Med 2:176–185PubMedCrossRefGoogle Scholar
  57. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection [published erratum appears in Mol Cell Biol 1992 Jan;12(1):433]. Mol Cell Biol 10:4239–4242PubMedGoogle Scholar
  58. Mitrophanous K, Yoon S, Rohll J, Patil D, Wilkes F, Kim V, Kingsman S, Kingsman A, Mazarakis N (1999) Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther 6:1808–1818PubMedCrossRefGoogle Scholar
  59. Miyazawa T, Kawaguchi Y, Kohmoto M, Tomonaga K, Mikami T (1994) Comparative functional analysis of the various lentivirus long terminal repeats in human colon carcinoma cell line (SW480 cells) and feline renal cell line (CRFK cells). J Vet Med Sci 56:895–899PubMedCrossRefGoogle Scholar
  60. Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM (1998) Development of a self-inactivating lentivirus vector. J Virol 72:8150–8157PubMedGoogle Scholar
  61. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE (1999) Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682–686PubMedCrossRefGoogle Scholar
  62. Miyoshi H, Takahashi M, Gage FH, Verma IM (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 94:10319–10323PubMedCrossRefGoogle Scholar
  63. Mselli-Lakhal L, Favier C, Da Silva Teixeira MF, Chettab K, Legras C, Ronfort C, Verdier G, Mornex JF, Chebloune Y (1998) Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors. Arch Virol 143:681–695PubMedCrossRefGoogle Scholar
  64. Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263–267PubMedCrossRefGoogle Scholar
  65. Narayan O, Clements JE (1988) Biology and pathogenesis of ruminant animals. In: Wong-Staal F, Gallo RC (eds) Retrovirus biology: an emerging role in human biology. Marcel Dekker, New YorkGoogle Scholar
  66. Nowotny N, Uthman A, Haas OA, Borkhardt A, Lechner K, Egberink HF, Möstl K, Horzinek MC (1995) Is it possible to catch leukemia from a cat? Lancet 346:252–253PubMedCrossRefGoogle Scholar
  67. Olsen JC (1998) Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 5: 1481–1487PubMedCrossRefGoogle Scholar
  68. Park F, Ohashi K, Chiu W, Naldini L, Kay MA (2000) Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat Genet 24:49–52PubMedCrossRefGoogle Scholar
  69. Park F, Ohashi K, Kay MA (2000) Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 96:1173–1176PubMedGoogle Scholar
  70. Pétursson G, Turelli P, Matthiasdóttir S, Georgsson G, Andrésson OS, Torsteinsdóttir S, Vigne R, Andrésdóttir V, Gunnarsson E, Agnarsdóttir G, Quérat G (1998) Visna virus dUTPase is dispensable for neuropathogenicity. J Virol 72:1657–1661PubMedGoogle Scholar
  71. Phillips TR, Lamont C, Konings DA, Shacklett BL, Hamson CA, Luciw PA, Elder JH (1992) Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J Virol 66:5464–5471PubMedGoogle Scholar
  72. Poeschla EM, Looney DJ (1998) CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J Virol 72:6858–6866PubMedGoogle Scholar
  73. Poeschla EM, Wong-Staal F, Looney DJ (1998) Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. Nat Med 4:354–357PubMedCrossRefGoogle Scholar
  74. Powell S, Kaloss M, Pinkstaff A, McKee R, Burimski I, Pensiero M, Otto E, Stemmer W, Soong N (2000) Breeding of retroviruses by DNA shuffling for improved stability and processing yields. Nat Biotechnol 18:1279–1282PubMedCrossRefGoogle Scholar
  75. Power C, Buist R, Johnston JB, Del Bigio MR, Ni W, Dawood MR, Peeling J (1998) Neurovirulence in feline immunodeficiency virus-infected neonatal cats is viral strain specific and dependent on systemic immune suppression. J Virol 72:9109–9115PubMedGoogle Scholar
  76. Power C, Moench T, Peeling J, Kong PA, Langelier T (1997) Feline immunodeficiency virus causes increased glutamate levels and neuronal loss in brain. Neuroscience 77:1175–1185PubMedCrossRefGoogle Scholar
  77. Ramezani A, Hawley T, Hawley R (2000) Lentiviral Vectors for Enhaned Gene Expression in Human Hematopoietic Cells. Mol Ther 2:458–469PubMedCrossRefGoogle Scholar
  78. Reiser J (2000) Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 7:910–913PubMedCrossRefGoogle Scholar
  79. Rizvi TA, Schmidt RD, Lew KA (1997) Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner. Virology 236:118–129PubMedCrossRefGoogle Scholar
  80. Roe T, Reynolds TC, Yu G, Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. Embo Journal 12:2099–2108PubMedGoogle Scholar
  81. Schroers R, Sinha I, Segall H, Schmidt-Wolf IG, Rooney CM, Brenner MK, Sutton RE, Chen SY (2000) Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol Ther 1:171–179PubMedCrossRefGoogle Scholar
  82. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV (2000) Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen [see comments]. New Engl J Med 343:230–238PubMedCrossRefGoogle Scholar
  83. Snider TG, 3rd, Luther DG, Jenny BF, Hoyt PG, Battles JK, Ennis WH, Balady J, Blas-Machado U, Lemarchand TX, Gonda MA (1996) Encephalitis, lymphoid tissue depletion and secondary diseases associated with bovine immunodeficiency virus in a dairy herd. Comp Immunol Microbiol Infect Dis 19:117–131PubMedCrossRefGoogle Scholar
  84. Soeharsono S, Hartaningsih N, Soetrisno M, Kertayadnya G, Wilcox GE (1990) Studies of experimental Jembrana disease in Bali cattle. I. Transmission and persistence of the infectious agent in ruminants and pigs, and resistance of recovered cattle to re-infection. J Comp Pathol 103:49–59PubMedCrossRefGoogle Scholar
  85. Soeharsono S, Wilcox GE, Putra AA, Hartaningsih N, Sulistyana K, Tenaya M (1995) The transmission of Jembrana disease, a lentivirus disease of Bos javanicus cattle. Epidemiol Infect 115:367–374PubMedCrossRefGoogle Scholar
  86. Steagall WK, Robek MD, Perry ST, Fuller FJ, Payne SL (1995) Incorporation of uracil into viral DNA correlates with reduced replication of EIAV in macrophages. Virology 210:302–313PubMedCrossRefGoogle Scholar
  87. Stetor SR, Rausch JW, Guo MJ, Burnham JP, Boone LR, Waring MJ, Le Grice SF (1999) Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome. Biochemistry 38:3656–3667PubMedCrossRefGoogle Scholar
  88. Stitz J, Buchholz CJ, Engelstadter M, Uckert W, Bloemer U, Schmitt I, Cichutek K (2000) Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273:16–20PubMedCrossRefGoogle Scholar
  89. Tomonaga K, Miyazawa T, Kawaguchi Y, Kohmoto M, Inoshima Y, Mikami T (1994) Comparison of the Rev transactivation of feline immunodeficiency virus in feline and non-feline cell lines. J Vet Med Sci 56:199–201PubMedCrossRefGoogle Scholar
  90. Tomonaga K, Shin YS, Fukasawa M, Miyazawa T, Adachi A, Mikami T (1993) Feline immunodeficiency virus gene expression: analysis of the RNA splicing pattern and the monocistronic rev mRNA. J Gen Virol 74:2409–2417PubMedCrossRefGoogle Scholar
  91. Turelli P, Pétursson G, Guiguen F, Mornex JF, Vigne R, Quérat G (1996) Replication properties of dUTPase-deficient mutants of caprine and ovine lentiviruses. J Virol 70:1213–1217PubMedGoogle Scholar
  92. Uchida N, Sutton RE, Friera AM, He D, Reitsma MJ, Chang WC, Veres G, Scollay R, Weissman IL (1998) HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA 95:11939–11944PubMedCrossRefGoogle Scholar
  93. Wang G, Slepushkin V, Zabner J, Keshavjee S, Johnston JC, Sauter SL, Jolly DJ, Dubensky TW Jr, Davidson BL, McCray PB Jr (1999) Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic flbrosis defect [see comments]. J Clin Invest 104:R55–R62PubMedCrossRefGoogle Scholar
  94. Yang S, Delgado R, King SR, Woffendin C, Barker CS, Yang ZY, Xu L, Nolan GP, Nabel GJ (1999) Generation of retroviral vector for clinical studies using transient transfection. Hum Gene Ther 10:123–132PubMedCrossRefGoogle Scholar
  95. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Chameau P (2000) HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap. Cell 101:173–185PubMedCrossRefGoogle Scholar
  96. Zufferey R, Donello JE, Trono D, Hope TJ (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73: 2886–2892PubMedGoogle Scholar
  97. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871–875PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • M. A. Curran
    • 1
  • G. P. Nolan
    • 1
  1. 1.Department of Molecular PharmacologyStanford UniversityStanfordUSA

Personalised recommendations